Resistant depression : potentiation strategies

被引:3
|
作者
Doumy, Olivier [1 ]
Bennabi, Djamila [2 ]
El-Hage, Wissam [3 ]
Allaili, Najib [4 ]
Bation, Remy [5 ]
Bellivier, Frank [4 ]
Holtzmann, Jerome [6 ]
Bubrovszky, Maxime [7 ]
Camus, Vincent [3 ]
Charpeaud, Thomas [8 ]
Courvoisier, Pierre [6 ]
d'Amato, Thierry [5 ]
Garnier, Marion [8 ]
Haesebaert, Frederic [5 ]
Bougerol, Thierry [6 ]
Lancon, Christophe [9 ]
Moliere, Fanny [10 ]
Nieto, Isabel [4 ]
Richieri, Raphaelle [9 ]
Saba, Ghassen [11 ]
Courtet, Philippe [10 ]
Vaiva, Guillaume [7 ]
Leboyer, Marion [11 ]
Llorca, Pierre-Michel [8 ]
Aouizerate, Bruno [1 ]
Haffen, Emmanuel [2 ]
机构
[1] CH Charles Perrens, Ctr Expert Depress Resistante FondaMental, Pole Psychiat Gen & Univ, F-33076 Bordeaux, France
[2] CHU Besancon, Serv Psychiat Adulte, Ctr Expert Depress Resistante FondaMental, F-25030 Besancon, France
[3] CHU Tours, Ctr Expert Depress Resistante FondaMental, Clin Psychiat Univ, F-37044 Tours 9, France
[4] Hop Fernand Widal, Serv Psychiat Adulte, Ctr Expert Depress Resistante FondaMental, F-75010 Paris, France
[5] Ctr Hosp Le Vinatier, Ctr Expert Depress Resistante FondaMental, Serv Univ Psychiat Adulte, F-69678 Bron, France
[6] CHU Grenoble, Hop Nord, Ctr Expert Depress Resistante FondaMental, Serv Psychiat Adulte, CS 10217, F-38043 Grenoble 9, France
[7] CHRU Lille, Hop Fontan 1, Serv Psychiat Adulte, Ctr Expert Depress Resistante FondaMental, F-59037 Lille, France
[8] CHU Clermont Ferrand, Ctr Expert Depress Resistante FondaMental, Serv Psychiat Adulte B, F-63003 Clermont Ferrand, France
[9] CHU La Concept, Ctr Expert Depress Resistante FondaMental, Pole Psychiat Ctr, F-13005 Marseille, France
[10] CHRU Lapeyronie, Dept Urgences & Posturgences Psychiat, Ctr Expert Depress Resistante FondaMental, F-34295 Montpellier 5, France
[11] Hop Univ Henri Mondor, Hop Chenevier, Pole Psychiat, Ctr Expert Depress Resistante FondaMental, F-94000 Creteil, France
来源
PRESSE MEDICALE | 2016年 / 45卷 / 03期
关键词
EXTENDED-RELEASE QUETIAPINE; PLACEBO-CONTROLLED TRIAL; SEROTONIN REUPTAKE INHIBITORS; STAR-ASTERISK-D; DOUBLE-BLIND; OLANZAPINE/FLUOXETINE COMBINATION; ARIPIPRAZOLE AUGMENTATION; REFRACTORY DEPRESSION; TRIIODOTHYRONINE AUGMENTATION; RISPERIDONE AUGMENTATION;
D O I
10.1016/j.lpm.2016.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lithium is among the most classically recommended add-on therapeutic strategy for the management of depressive patients showing unsuccessful response to standard antidepressant medications. The effectiveness of the add-on strategy with lithium requires achieving plasma levels above 0.5 mEq/L. Mood-stabilizing antiepileptic drugs such as carbamazepine, valproate derivatives or lamotrigine have not demonstrated conclusive therapeutic effects for the management of depressive patients showing unsuccessful response to standard antidepressant medications. Thyroid hormones are considered among the currently recommended add-on therapeutic strategy for the management of depressive patients showing unsuccessful response to standard antidepressant medications. The effectiveness of the add-on strategy with thyroid hormones requires achieving plasma concentration of TSH close to the lower limits at the normal range (0.4 mUI/L) or even below it. Second-generation antipsychotics such as aripiprazole or quetiapine have consistently demonstrated significant therapeutic effects for the management of depressive patients showing unsuccessful response to standard antidepressant medications. Second-generation antipsychotics however require the careful monitoring of both cardiovascular and metabolic adverse effects.
引用
收藏
页码:338 / 349
页数:12
相关论文
共 50 条
  • [21] Treatment-Resistant Depression Identification and Treatment Strategies
    Limandri, Barbara J.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (09) : 11 - 15
  • [22] Resistant depression : Switching and combining strategies of antidepressant medications
    Charpeaud, Thomas
    Moliere, Fanny
    Bubrovszky, Maxime
    Haesebaert, Frederic
    Allaili, Najib
    Bation, Remy
    Nieto, Isabel
    Richieri, Raphaelle
    Saba, Ghassen
    Bellivier, Frank
    Bennabi, Djamila
    Holtzmann, Jerome
    Camus, Vincent
    Courtet, Philippe
    Courvoisier, Pierre
    d'Amato, Thierry
    Doumy, Olivier
    Garnier, Marion
    Bougerol, Thierry
    Lancon, Christophe
    Haffen, Emmanuel
    Leboyer, Marion
    Llorca, Pierre-Michel
    Vaiva, Guillaume
    El-Hage, Wissam
    Aouizerate, Bruno
    PRESSE MEDICALE, 2016, 45 (03): : 329 - 337
  • [23] The concept of resistant depression and therapeutic strategies, particularly with venlafaxine
    Poirier, MF
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 55 - 57
  • [24] The concept of resistant depression and therapeutic strategies, particularly with venlafaxine
    Guelfi, JD
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 58 - 59
  • [25] Augmentation strategies for treatment-resistant depression: a literature review
    Carvalho, A. F.
    Cavalcante, J. L.
    Castelo, M. S.
    Lima, M. C. O.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 415 - 428
  • [26] The concept of resistant depression and therapeutic strategies, particularly with venlafaxine -: Discussion
    Lôo, H
    Peretti, CS
    Poirier, MF
    Bourin, M
    Lecrubier, Y
    Chignon, M
    Guelfi, JD
    Rivet, M
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 60 - 61
  • [27] Moderators of response to next-step strategies in resistant depression
    Fava, Maurizio
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S38 - S38
  • [28] Moderators of response to next-step strategies in resistant depression
    Fava, Maurizio
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 199S - 199S
  • [29] Treatment-resistant depression in the age of serotonin: evolving strategies
    O'Reardon, JP
    Brunswick, DJ
    Amsterdam, JD
    CURRENT OPINION IN PSYCHIATRY, 2000, 13 (01) : 93 - 98
  • [30] Novel drug developmental strategies for treatment-resistant depression
    Borbely, Eva
    Simon, Maria
    Fuchs, Eberhard
    Wiborg, Ove
    Czeh, Boldizsar
    Helyes, Zsuzsanna
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (06) : 1146 - 1186